Leerink Partners adjusted their financial outlook on Cencora Inc (NYSE: COR), increasing the price target to $301 from the previous $287 while keeping an Outperform rating on the stock. The revision ...

Shares of Cencora Inc. COR slid 2.82% to $246.13 Thursday, on what proved to be an all-around mixed trading session for the ...

Investors need to pay close attention to Cencora (COR) stock based on the movements in the options market lately. Wells Fargo lowered the firm’s price target on Cencora (COR) to $237 from $249 ...

Shares of Cencora, Inc. (NYSE:COR – Get Free Report) reached a new 52-week high on Wednesday after the company announced ...

The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Investors need to pay close attention to Cencora (COR) stock based on the movements in the options market lately. Wells Fargo lowered the firm’s price target on Cencora (COR) to $237 from $249 ...

Therefore, the Zacks rating upgrade for Cencora basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price. The change in ...

Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in ...

Momentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook ... Chesterbrook, PA-based Cencora is one of the world’s largest pharmaceutical ...

Analysts have recently evaluated Cencora and provided 12-month price targets. The average target is $281.67, accompanied by a high estimate of $301.00 and a low estimate of $237.00. This current ...